“Chuncheon, a Digital Healthcare Hub” — 2025 Medical AI Forum Held in Chuncheon

“Chuncheon, a Digital Healthcare Hub” — 2025 Medical AI Forum Held in Chuncheon

“Chuncheon, a Digital Healthcare Hub” — 2025 Medical AI Forum Held in Chuncheon

“Chuncheon, a Digital Healthcare Hub” — 2025 Medical AI Forum Held in Chuncheon

25. 3. 23.

25. 3. 23.

“Chuncheon, a Digital Healthcare Hub” — 2025 Medical AI Forum Held in Chuncheon

“Chuncheon, a Digital Healthcare Hub” — 2025 Medical AI Forum Held in Chuncheon

At the 2025 Medical AI Chuncheon Forum, Chuncheon Mayor Dong-han Yuk and Minister of Health and Welfare Kyu-hong Cho emphasized the importance of fostering the digital healthcare industry. Suji Hong, CEO of Oprimed Co., Ltd., presented on the topic “Global Innovation Park Based on AI Digital Twin.”

At the 2025 Medical AI Chuncheon Forum, Chuncheon Mayor Dong-han Yuk and Minister of Health and Welfare Kyu-hong Cho emphasized the importance of fostering the digital healthcare industry. Suji Hong, CEO of Oprimed Co., Ltd., presented on the topic “Global Innovation Park Based on AI Digital Twin.”

Suji Hong, CEO of Oprimed Co., Ltd., delivered a spotlight presentation at the 2025 Medical AI Chuncheon Forum on the theme “Global Innovation Park Based on AI Digital Twin.”
She introduced Oprimed’s AI-powered digital twin platform, OPTIVIS, which enhances clinical trial efficiency and reduces time and costs in drug development.
Oprimed is accelerating its entry into the global digital healthcare market with this innovative technology.
The forum, held under the theme “Chuncheon as a Hub for Digital Healthcare,” was attended by Minister of Health and Welfare Kyu-hong Cho and Chuncheon Mayor Dong-han Yuk.
Both officials emphasized the need to foster AI-based healthcare industries and committed to expanding government investment and regulatory reform.
Chuncheon is planning to establish innovation parks and specialized clusters to become a leading city in digital healthcare.
The forum also addressed future strategies in four key areas: digital health, precision medicine, K-Bio, and AI digital twins.

Suji Hong, CEO of Oprimed Co., Ltd., delivered a spotlight presentation at the 2025 Medical AI Chuncheon Forum on the theme “Global Innovation Park Based on AI Digital Twin.”
She introduced Oprimed’s AI-powered digital twin platform, OPTIVIS, which enhances clinical trial efficiency and reduces time and costs in drug development.
Oprimed is accelerating its entry into the global digital healthcare market with this innovative technology.
The forum, held under the theme “Chuncheon as a Hub for Digital Healthcare,” was attended by Minister of Health and Welfare Kyu-hong Cho and Chuncheon Mayor Dong-han Yuk.
Both officials emphasized the need to foster AI-based healthcare industries and committed to expanding government investment and regulatory reform.
Chuncheon is planning to establish innovation parks and specialized clusters to become a leading city in digital healthcare.
The forum also addressed future strategies in four key areas: digital health, precision medicine, K-Bio, and AI digital twins.

Suji Hong, CEO of Oprimed Co., Ltd., delivered a spotlight presentation at the 2025 Medical AI Chuncheon Forum on the theme “Global Innovation Park Based on AI Digital Twin.”
She introduced Oprimed’s AI-powered digital twin platform, OPTIVIS, which enhances clinical trial efficiency and reduces time and costs in drug development.
Oprimed is accelerating its entry into the global digital healthcare market with this innovative technology.
The forum, held under the theme “Chuncheon as a Hub for Digital Healthcare,” was attended by Minister of Health and Welfare Kyu-hong Cho and Chuncheon Mayor Dong-han Yuk.
Both officials emphasized the need to foster AI-based healthcare industries and committed to expanding government investment and regulatory reform.
Chuncheon is planning to establish innovation parks and specialized clusters to become a leading city in digital healthcare.
The forum also addressed future strategies in four key areas: digital health, precision medicine, K-Bio, and AI digital twins.

Suji Hong, CEO of Oprimed Co., Ltd., delivered a spotlight presentation at the 2025 Medical AI Chuncheon Forum on the theme “Global Innovation Park Based on AI Digital Twin.”
She introduced Oprimed’s AI-powered digital twin platform, OPTIVIS, which enhances clinical trial efficiency and reduces time and costs in drug development.
Oprimed is accelerating its entry into the global digital healthcare market with this innovative technology.
The forum, held under the theme “Chuncheon as a Hub for Digital Healthcare,” was attended by Minister of Health and Welfare Kyu-hong Cho and Chuncheon Mayor Dong-han Yuk.
Both officials emphasized the need to foster AI-based healthcare industries and committed to expanding government investment and regulatory reform.
Chuncheon is planning to establish innovation parks and specialized clusters to become a leading city in digital healthcare.
The forum also addressed future strategies in four key areas: digital health, precision medicine, K-Bio, and AI digital twins.

Suji Hong, CEO of Oprimed Co., Ltd., delivered a spotlight presentation at the 2025 Medical AI Chuncheon Forum on the theme “Global Innovation Park Based on AI Digital Twin.”
She introduced Oprimed’s AI-powered digital twin platform, OPTIVIS, which enhances clinical trial efficiency and reduces time and costs in drug development.
Oprimed is accelerating its entry into the global digital healthcare market with this innovative technology.
The forum, held under the theme “Chuncheon as a Hub for Digital Healthcare,” was attended by Minister of Health and Welfare Kyu-hong Cho and Chuncheon Mayor Dong-han Yuk.
Both officials emphasized the need to foster AI-based healthcare industries and committed to expanding government investment and regulatory reform.
Chuncheon is planning to establish innovation parks and specialized clusters to become a leading city in digital healthcare.
The forum also addressed future strategies in four key areas: digital health, precision medicine, K-Bio, and AI digital twins.

Suji Hong, CEO of Oprimed Co., Ltd., delivered a spotlight presentation at the 2025 Medical AI Chuncheon Forum on the theme “Global Innovation Park Based on AI Digital Twin.”
She introduced Oprimed’s AI-powered digital twin platform, OPTIVIS, which enhances clinical trial efficiency and reduces time and costs in drug development.
Oprimed is accelerating its entry into the global digital healthcare market with this innovative technology.
The forum, held under the theme “Chuncheon as a Hub for Digital Healthcare,” was attended by Minister of Health and Welfare Kyu-hong Cho and Chuncheon Mayor Dong-han Yuk.
Both officials emphasized the need to foster AI-based healthcare industries and committed to expanding government investment and regulatory reform.
Chuncheon is planning to establish innovation parks and specialized clusters to become a leading city in digital healthcare.
The forum also addressed future strategies in four key areas: digital health, precision medicine, K-Bio, and AI digital twins.

Connecting to

a Better Future

Meet OPRIMED today.

OPRIMED Inc.

CEO Suji Hong

Business Registration Number

277-87-02894

Headquarters (Ulsan)

Room 601, Ulsan Startup Hub,Jongha Innovation Center,

32, Bongwol-ro 38beon-gil,

Nam-gu, Ulsan, South Korea

info@oprimed.com

Big Data Lab (Suwon)

10th Floor, Room 1001,

Gwanggyo Central Business

Tower, 260 Changnyong-daero, Yeongtong-gu, Suwon,

Gyeonggi Province





© 2025 OPRIMED INC. (All Rights Reserved)

Connecting to

a Better Future

Meet OPRIMED today.

OPRIMED Inc.

CEO Suji Hong

Business Registration Number

277-87-02894

Headquarters (Ulsan)
Room 601, Ulsan Startup Hub,Jongha Innovation Center,

32, Bongwol-ro 38beon-gil,

Nam-gu, Ulsan, South Korea

info@oprimed.com

Big Data Lab (Suwon)
10th Floor, Room 1001,

Gwanggyo Central Business

Tower, 260 Changnyong-daero,
Yeongtong-gu, Suwon,

Gyeonggi Province







© 2025 OPRIMED Inc. (All Rights Reserved)

Connecting to

a Better Future

Meet OPRIMED today.

OPRIMED Inc.

CEO Suji Hong

Business Registration Number

277-87-02894

Headquarters (Ulsan)
Room 601, Ulsan Startup Hub,Jongha Innovation Center,

32, Bongwol-ro 38beon-gil,

Nam-gu, Ulsan, South Korea

info@oprimed.com

Big Data Lab (Suwon)
10th Floor, Room 1001,

Gwanggyo Central Business

Tower, 260 Changnyong-daero,
Yeongtong-gu, Suwon,

Gyeonggi Province







© 2025 OPRIMED Inc. (All Rights Reserved)

© 2025 OPRIMED Inc. (All Rights Reserved)

Connecting to

a Better Future

Meet OPRIMED

today.

OPRIMED Inc.

CEO Suji Hong

Business Registration Number

277-87-02894

Headquarters (Ulsan)

Room 601, Ulsan Startup Hub,

Jongha Innovation Center,

32, Bongwol-ro 38beon-gil,

Nam-gu, Ulsan, South Korea

Big Data Lab (Suwon)

10th Floor, Room 1001,

Gwanggyo Central Business Tower, 260 Changnyong-daero,

Yeongtong-gu, Suwon,

Gyeonggi Province

info@oprimed.com